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Abstract 
A case of idiopathic hypertrophic cranial pachymeningitis with an unusual and misleading manifestation is 
reported. Computed tomography scan, angiographic and magnetic resonance imaging findings were suggestive 
of multiple meningeal neoplasms and a correct diagnosis was made only after meningeal biopsy. This 44-year-
old patient had a previous history of an ill-defined systemic disorder associating episcleritis, erythroderma 
nodosa and multiple peripheral arthritis. We review previous reports of idiopathic cranial pachymeningitis with 
emphasis on radiological investigation techniques, histopathology and possible dysimmune mechanisms of 
pathogenesis. 
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Introduction 
Idiopathic hypertrophic cranial pachymeningitis (IHCP) is a chronic and progressive inflammatory disease that 
usually results in a diffuse thickening of the dura mater. It often causes headaches and multiple cranial nerve 
palsies due to fibrous entrapment or ischemic damage. Although several etiologies, either infectious or 
autoimmune, have been suggested, most aspects of this rare disease remain to be elucidated. We report a case 
with the unusual and misleading features of multiple meningeal tumors occurring in a middle-aged 
immunodepressed woman with dysimmune status. 
Case report 
This 44-year-old Caucasian woman first came to medical attention in 1983 for a bilateral episcleritis pursuing an 
aggressive course, and eventually progressing towards scleromalacy. Initial therapy with oral 
methylprednisolone 8 mg/day was complicated by bilateral cataract and was replaced with azathioprine 100 
mg/day in 1989. 
In 1984, she suffered an episode of lower limb erythroderma nodosa and tibio-tarsal arthritis with transient 
concomittant increase of anti-streptokinase and anti-streptolysin antibody titers, prompting a course of penicillin 
and salicylates. Other osteoarticular manifestations included metatarso-phalangeal synovitis in 1985 and 
calcaneitis in 1989. Exhaustive evaluation for systemic disease failed to disclose any other parenchymal 
involvement. The following laboratory studies were normal: complete blood count, erythrocyte sedimentation 
rate, C-reactive protein, serum and urine chemistry, immunoglobulins, C3-C4, and thyroid hormones. Serum 
antibody titers for Aspergillus, Chlamydia, Yersinia, Brucella, Salmonella and Treponema pallidum were 
negative. Angiotensin converting enzyme (ACE) titer was normal. Antinuclear antibody titer was positive at 
1:320 with a homogenous and speckled pattern. The serum was negative for rheumatoid factor, anti-cardiolipin 
antibody, anti-ribonucleoprotein, anti-Smith, anti-double strand DNA, SS-A and SS-B. HLA-typing was 
A10A28 B12B18 CWO DR2 DR5. 
In November 1993, she complained of left hearing loss, headaches and dizziness. Physical examination, 
including detailed neurological testing, was normal except for a left cochleovestibular deficit. Laboratory studies 
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on serum and CSF were unrevealing. Brain computed tomography scan showed two infratentorial meningeal and 
one supratentorial tumor, which were isodense and intensively enhanced after contrast injection. These lesions 
appeared isointense on T1-weighted magnetic resonance imaging, intensively enhanced after gadolinium-DTPA 
administration (Fig. 1) and hypointense on T2-weighted sequences. They had a large implantation on the dura 
mater, without remodeling underlying bone structures. No diffuse thickening of the dura mater was observed. 
Carotid and vertebral angiography was normal and the tumors appeared poorly vascularized. A posterior fossa 
craniectomy was performed and the dural-based left nodule was almost totally resected; histopathology 
demonstrated a non-caseous necrotizing granulomatous pachymeningitis of unknown etiology. There was no 
vasculitis. Specific stains were negative for fungi and acid-fast bacilli. Subsequent evaluation for pathogens in 
CSF and serum samples remained negative. 
Local recurrence and continuous growth of the other masses, despite immunosuppressive therapy with 
azathioprine 100 mg/day, prompted a second resection performed on the supratentorial lesion in December 1995. 
This firm and homogeneously whitish 3-cm tumor was anchored on the dura mater and was well demarcated 
from leptomeninges by a smooth dome-shaped outline. Microscopic examination showed a dense fibrous tissue 
infiltrated by plasma cells, lymphocytes, polymorphs, eosinophils and histiocytes often organized in non-caseous 
necrotizing granulomas (Fig. 2). Specific stains and culture for bacteria and fungi on biopsy samples were 
unremarkable. Immunohistochemical studies of the plasma cell population for heavy and light chains of 
immunoglobu-lins demonstrated a polyclonal phenotype; immunostaining for protein S-100, vimentin and 
epithelial membrane antigen showed no meningothelial proliferation. A diagnosis of IHCP was proposed, with 
possible dysimmune etiology. Post-operative evolution was marked by the appearance of right hearing loss. The 
patient is currently treated with oral methylprednisolone 8 mg daily and a monthly intravenous pulse of 
cyclophosphamide 500 mg/m2. 
 
Fig. 1 A, B Cranial magnetic resonance imaging: T1-weighted image after gadolinium-DTPA injection. A 
Bilateral infratentorial meningeal tumor in the vicinity of jugular foramens. B Isointense supratentorial 
pterional meningeal mass 
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Fig. 2 A, B  Biopsy specimen from the pterional mass. A Necrotizing granuloma with giant cells in a dense 
fibrous tissue infiltrated by polymorphs, eosinophils and plasma cells. B Necrotic areas are filled with pycnotic 
pleomorphs without caseous formation or fibrinoid deposition. A, B Hematoxylin, eosin and safran stain; A × 




Clinical, neuroimaging and histopathological findings of our case are consistent with those of IHCP except that 
dura mater involvement was not diffuse but nodular, mimicking multiple meningeal tumors. 
Severe headaches and eighth cranial nerve pair dysfunction were the major clinical manifestations of our patient. 
Headache is a prominent symptom of IHCP, which is responsive to corticotherapy but not to CSF diversion. It 
most often reflects meningeal irritation by an inflammatory process rather than increased intracranial pressure; 
only three cases of IHCP-related hydrocephalus are reported in the literature [2]. Blindness caused by optic nerve 
compression, palsies of eighth, fifth, seventh and lower cranial nerves and cerebellar ataxia have also been 
reported [2, 17]. 
Recent progress in neuroimaging has given rise to an increase in the reporting of IHCP. Two major patterns of 
pachymeningeal hypertrophy are generally encountered: one located in the parasellar and cavernous regions, 
with entrapment of the cavernous and supraclinoidal segment of the internal carotid artery and optic nerves [15, 
32]; and a second more frequent syndrome affecting the falcotentorial and clival dura mater with multiple cranial 
nerve involvement [7, 14]. To the best of our knowledge, nodular pseudo-tumoral thickening of dura mater has 
Published in : Acta Neuropathologica (1997), vol. 94, pp. 385-389. 
Status : Postprint (Author’s version) 
 
been reported previously in only five cases of IHCP [16-18]. Lesions appeared isolated [16-18] or associated 
with diffuse thickening of falcotentorial pachymeninges [16, 18]. One case showed local recurrence [16]. 
Multiple synchronous meningeal tumors as a manifestation of IHCP have never been reported before and 
neuroradiological features of our case seem to be unique. Our observation and previous reports [16-18] lay 
emphasis on the necessity for considering IHCP as part of the differential diagnosis of meningeal tumors. 
Histopathological features of IHCP encompass pachymeningeal fibrosis and an inflammatory infiltration of 
various cellular admixtures. Granulomas, whether necrotizing or not, have been reported occasionally [16]. In 
the case under discussion, the presence of uni-or multi-nucleated histiocytes organized in non-caseous 
necrotizing granulomas was a prominent feature. As previous authors, we can not explain the pathogenesis of the 
disease. 
Bacterial (Treponema pallidum [6, 21], Mycobacterium tuberculosis [3, 19]) and fungal (Candida species [9], 
Aspergillus flavus [22], Petriellidum boydii [27]) infections have been reported to cause hypertrophic cranial 
pachymeningitis. Because this immunodepressed patient was at higher risk with regard to opportunistic 
infection, a broad range of tests for bacterial, fungal and protozoan pathogens was performed. Extensive 
evaluation of CSF, serum and biopsy specimens remained negative. The possibility of dural thickening 
accompanying otorhinolaryngological disease was also rejected on the basis of clinical and radiological features. 
Central nervous system involvement in sarcoidosis may occur with hypertrophic pachymeningitis and mimick 
meningioma [26]. The fact that the patient's serum ACE titer was within normal range and the histological 
findings showed numerous necrotizing ganulomas did not favor such a diagnosis. 
Meningeal inflammatory masses of the dura [20] constitute an heterogeneous group of uncertain etiology that 
has been reported under various names such as plasma cell granuloma [5, 20, 31], hyalinizing plasmacytic 
granulomatosis [23] or inflammatory pseudo-tumour [5] because of their similarity to the lesions described in the 
lungs and other tissues [4]. The proportions of inflammatory and meningothelial components varied from case to 
case; some might have been true meningioma with a striking inflammatory component [11, 20], other were 
inflammatory masses with nests of trapped hyperplastic meningothelial cells. In all cases, inflammation was not 
accounted for by an infectious agent, a malignancy or a recognized systemic disorder. Inflammatory cells 
consisted predominantly of polyclonal plasma cells and lymphocytes with germinal center formation, and 
histiocytes associated with a various degree of fibrosis. No granulomas were described. The histopathological 
features of our case do not correspond to this entity as no meningothelial cells were seen and necrotizing 
granuloma were a common finding. Nevertheless, pseudotumoral IHCP and inflammatory pseudotumor might 
turn out to be various expressions of a same basic disorder. We searched for vasculitis lesions but could not find 
any neuroradiological or histological criteria in our patient. 
Hypertrophic cranial pachymeningitis has been reported in association with systemic diseases such as 
rheumatoid arthritis [13, 28, 30, 33], polyarteritis nodosa [1] and Wegener's granulomatosis [8, 24]. Our patient 
had a previous history of long-lasting rheumatic disease associating episcleritis, multiple peripheral arthritis and 
erythroderma nodosa. Laboratory findings showed a positive titer of antinuclear antibodies (ANA) at 1:320 and 
DR2 allel on HLA typing. These nonspecific manifestations do not fit the classification criteria for a specific 
systemic disorder as defined by the American College of Rheumatology, but clearly indicate a dysimmune 
status. An autoimmune or dysimmune mechanism in the pathogenesis of IHCP has been suggested previously 
for a patient associating IHCP, myocarditis with a high serum ANA titer [29] and in a recent report on IHCP 
occurring in HTLV-1-infected patients [12]. 
Optimal therapy relies on achievement of a better understanding of the pathogeny of IHCP. In the meanwhile, 
empiric trials have used radiotherapy, azathioprine and corticosteroids. A high dosage of oral 
methylprednisolone seems to be the most effective therapy but relapse frequently occurs when tapering the 
dosage. Spontaneous regression has also been reported [25]. Clearly, more reports with a longer follow-up are 
warranted before establishing the natural history of the disease and the efficacy of therapy. 
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